Misplaced Pages

Jones Pharma

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Jones Pharma" – news · newspapers · books · scholar · JSTOR (June 2010) (Learn how and when to remove this message)
This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources.
Find sources: "Jones Pharma" – news · newspapers · books · scholar · JSTOR (June 2010) (Learn how and when to remove this message)
This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (July 2010) (Learn how and when to remove this message)
(Learn how and when to remove this message)

Jones Pharma is a specialty pharmaceuticals manufacturer and marketer based in St. Louis, Missouri. The company was founded on March 16, 1981, by Dennis M. Jones and Judith Pearce Jones under the name Jones Medical Industries. The company completed its initial public offering in 1986, trading under the ticker symbol JMED on the NASDAQ. The primary therapeutic compounds marketed by the company include Thrombin-JMI and Levoxyl. On May 30, 2000, the company became a wholly owned subsidiary of King Pharmaceuticals (NYSE:KG), based in Bristol, Tennessee. The market value of the company on its closing trade was $3.6 billion. Parent company King Pharmaceuticals was acquired by Pfizer in 2010.

References

  1. "Thrombin-Jmi". thrombin-jmi.com. Retrieved 2014-12-14.
  2. "Levoxyl® (levothyroxine sodium tablets, USP) | Safety Info". levoxyl.com. Retrieved 2014-12-14.
  3. prnewswire.com Archived 2011-04-03 at the Wayback Machine
  4. "Dennis Jones - St. Louis Business Journal". bizjournals.com. Retrieved 2014-12-14.
  5. "Pfizer to buy King Pharma for $3.6 billion in cash". Reuters. 2010-10-12. Retrieved 2020-08-06.
  6. Rockoff, Jonathan D. (2010-10-13). "Pfizer to Buy King Pharmaceuticals". Wall Street Journal. ISSN 0099-9660. Retrieved 2020-08-06.

External links

Categories: